New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Neuphoria Therapeutics Inc. (NEUP) vs Quantum Biopharma Ltd. (QNTM)
- Neuphoria Therapeutics Inc. NEUP 2.35 +1.29%
- Quantum Biopharma Ltd. QNTM 1.29 −9.15%
Neuphoria Therapeutics Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. Neuphoria Therapeutics Inc. and Quantum Biopharma Ltd. are of similar size ($12.6M and $12.6M). Across the 12 metrics below, Neuphoria Therapeutics Inc. leads on 7 and Quantum Biopharma Ltd. on 5.
Valuation
Profitability
| Metric | NEUP | QNTM | Biotechnology median |
|---|---|---|---|
| Gross margin | — | (1,068.29%) | 70.18% |
| Operating margin | — | (9,699.83%) | 0.00% |
| Net margin | — | (16,880.72%) | 0.00% |
| Free cash flow margin | — | (6,089.39%) | 0.00% |
| Return on equity | (27.63%) | (233.09%) | (51.58%) |
| Return on assets | (18.26%) | (127.92%) | (45.91%) |
| Return on invested capital | (186.04%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack